Related Experiment Video
Updated: May 16, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct
Hui-Chi Tsai1, David L Boucher, Anthony Martinez
1Department of Biochemistry & Molecular Medicine, School of Medicine and Cancer Center, University of California Davis, Davis, CA, USA.
Abstract:
Recent studies identifying putative truncated androgen receptor isoforms with ligand-independent activity have shed new light on the acquisition of androgen depletion independent (ADI) growth of prostate cancer. In this study, we present a model system in which a C-terminally truncated variant of androgen receptor (TC-AR) is inducibly expressed in LNCaP, an androgen-dependent cell line, which expresses little truncated receptor. We observed that when TC-AR is overexpressed, the endogenous full length receptor (FL-AR) is transcriptionally downmodulated. This in essence allows us to "replace" FL-AR with TC-AR and compare their individual properties in exactly the same genetic and cellular background, which has not been performed before. We show that the TC-AR translocates to the nucleus, activates transcription of AR target genes in the absence of DHT and is sufficient to confer ADI growth to the normally androgen dependent LNCaP line. We also show that while there is significant overlap in the genes regulated by FL- and TC-AR there are also differences in the respective suites of target genes with each AR form regulating genes that the other does not. Among the genes uniquely activated by TC-AR is RHOB which is shown to be involved in the increased migration and morphological changes observed in LN/TC-AR, suggesting a role of RHOB in the regulation of androgen-independent behavior of prostate cancer cells.
Insights
Truncated androgen receptor (TC-AR) drives androgen-independent prostate cancer growth by activating target genes without DHT. This study models TC-AR
Area of Science:
- Molecular Biology
- Cancer Research
- Endocrinology
Background:
- Prostate cancer (PCa) progression to androgen-independent (ADI) growth is linked to androgen receptor (AR) alterations.
- Putative truncated AR isoforms with ligand-independent activity are implicated in ADI PCa.
- Understanding the specific roles of full-length AR (FL-AR) versus truncated AR (TC-AR) is crucial for therapeutic strategies.
Purpose of the Study:
- To establish and utilize a novel inducible model system to compare the functions of TC-AR and FL-AR in prostate cancer cells.
- To investigate the ability of TC-AR to confer androgen-independent growth in an androgen-dependent cell line.
- To identify distinct transcriptional targets regulated by TC-AR compared to FL-AR.
Main Methods:
- Development of an inducible expression system for a C-terminally truncated AR (TC-AR) in LNCaP cells.
- Analysis of AR nuclear translocation, transcriptional activity, and target gene regulation in the presence and absence of dihydrotestosterone (DHT).
- Comparison of gene expression profiles regulated by FL-AR and TC-AR, including investigation of specific TC-AR-regulated genes like RHOB.
Main Results:
- Overexpression of TC-AR led to the downmodulation of endogenous FL-AR, allowing for a direct comparison of their functions.
- TC-AR translocated to the nucleus, activated AR target genes independently of DHT, and was sufficient to drive androgen-independent growth in LNCaP cells.
- Distinct sets of target genes were regulated by FL-AR and TC-AR, with RHOB identified as a key gene uniquely activated by TC-AR.
Conclusions:
- TC-AR can independently drive prostate cancer cell growth and migration, contributing to androgen-independent progression.
- RHOB, uniquely regulated by TC-AR, plays a role in the observed morphological changes and increased migration in TC-AR expressing cells.
- This study provides a valuable model for dissecting the distinct roles of AR isoforms in prostate cancer, highlighting TC-AR as a potential therapeutic target.
Related Concept Videos
Master Transcription Regulators
Co-activators and Co-repressors

